Researchers Reveal Another KRAS Inhibitor

被引：2
|
作者：
Leslie, Mitch
机构：
来源：
CANCER DISCOVERY | 2019年 / 9卷 / 09期
关键词：
D O I：
10.1158/2159-8290.CD-NB2019-092
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1152 / 1152
页数：1
相关论文
共 50 条
  • [21] Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors
    Choi, Yoonha
    Dharia, Neekesh V.
    Jun, Tomi
    Chang, Julie
    Royer-Joo, Stephanie
    Yau, Kenneth K.
    Assaf, Zoe J.
    Aimi, Junko
    Sivakumar, Smruthy
    Montesion, Meagan
    Sacher, Adrian
    LoRusso, Patricia
    Desai, Jayesh
    Schutzman, Jennifer L.
    Shi, Zhen
    CLINICAL CANCER RESEARCH, 2024, 30 (17) : 3788 - 3797
  • [22] METHAZOLAMIDE, ANOTHER CARBOANHYDRASE INHIBITOR
    MERKLE, W
    HEILMANN, K
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1979, 175 (06) : 865 - 865
  • [23] Another indication for thrombin inhibitor
    不详
    BIOTECHNOLOGY LAW REPORT, 2002, 21 (05) : 438 - 438
  • [24] KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance
    Ash, Leonard J.
    Busia-Bourdain, Ottavia
    Okpattah, Daniel
    Kamel, Avrosina
    Liberchuk, Ariel
    Wolfe, Andrew L.
    CURRENT ONCOLOGY, 2024, 31 (04) : 2024 - 2046
  • [25] KRAS inhibitor found after decades of searching
    Parks, Lisa
    FUTURE MEDICINAL CHEMISTRY, 2013, 5 (16) : 1907 - 1907
  • [26] SOS1 inhibitor combinations overcome KRAS inhibitor resistance
    Hofmann, Marco H.
    Jurado, Sabine
    NATURE CANCER, 2024, 5 (09) : 1294 - 1295
  • [27] ResponderID™ KRAS: Biology-driven machine learning to personalize KRAS inhibitor therapeutics
    Wheeler, Josh
    Lovse, Anze
    Ziberna, Klemen
    Stajdohar, Miha
    Ausec, Luka
    Kokosar, Janez
    Pointing, Daniel
    Pai, Aditya
    Rosengarten, Rafael
    Uhlik, Mark
    CANCER RESEARCH, 2024, 84 (06)
  • [28] Intrinsic resistance mechanisms to mutant KRAS specific inhibitor in KRAS mutated colorectal cancer
    Maruyama, Kohei
    Suzuki, Mai
    Ohhara, Tomoko
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2023, 114 : 1210 - 1210
  • [29] Intrinsic resistance mechanisms to mutant KRAS specific inhibitor in KRAS mutated colorectal cancer
    Maruyama, Kohei
    Suzuki, Mai
    Ohhara, Tomoko
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2023, 114 : 783 - 783
  • [30] Inhibitor combinations targeting KRAS effector signaling in KRAS-mutant pancreatic cancer
    Cox, Adrienne D.
    Goodwin, Craig M.
    Bryant, Kirsten L.
    Dagliyan, Irem
    George, Samuel D.
    Lucas, Kelly E.
    Gautam, Prson
    Wennerberg, Krister
    Der, Channing J.
    CANCER RESEARCH, 2018, 78 (13)
12345